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ABSTRACT  
Objectives 
Despite improvements in diagnostic and therapeutic approach to adult patients with bacterial 
meningitis, the overall mortality rate is still high. The aim of this study was to evaluate 
antibiotic timing in the course and outcome of bacterial meningitis..  
Methods  
Two hundred and eighty six patients with community-acquired bacterial meningitis aged 14 
years and more were included in this retrospective cohort study. Observational period was 
between 1 January 1990 and 31 December 2004. To assess the association of antibiotic timing 
and disease outcome we analyzed three timing periods (according to the onset of disease, 
onset of consciousness disturbance and the time of admission to hospital). Analysis was also 
performed in a subgroup of culture positive meningitis in 176 patients with altered mental 
status. 
Results 
Unfavorable outcome was found in 125 (43,7%) patients. In this group, the start of 
appropriate antibiotic treatment in relation to the onset of first symptoms and particularly to 
the onset of consciousness disturbance was significantly delayed (p=0,018 and p<0,001 
respectively) compared to the favorable group. Logistic regression analysis in a subgroup of 
culture positive meningitis in patients with altered mental status revealed that early adequate 
antibiotic treatment related to the onset of overt signs of meningitis was independently 
associated with favorable outcome (OR= 11,19; 95% CI 4,37-32,57; p<0,001). Advanced age, 
lower GCS and seizures (OR=1.05, OR=1,45 and OR= 3.65, respectively ) were other risk 
factors of poor outcome. The presence of chronic diseases, pneumococcal etiology and 
clinical and laboratory variables which are indicators of disease severity (renal and/or liver 
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dysfunction, hypotension and low cerebrospinal fluid glucose) were not confirmed as 
independent risk factors of poor outcome.  
Conclusions 
Our study emphasizes the importance of early and adequate antibiotic treatment in the 
management of bacterial meningitis which significantly enhances the chances for favorable 
outcome.  
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INTRODUCTION 
Despite advances in the treatment of severe infections, particularly associated with critical 
care medicine, many patients with bacterial meningitis have unfavorable outcome. Except for 
proved benefit from adjunctive corticosteroid treatment, particularly in pneumococcal 
disease, there are no significant improvements in diagnostic and therapeutic approach to adult 
patients with bacterial meningitis (1-4). The overall mortality rate before the routine use of 
dexamethasone was high, up to 28%, in pneumococcal meningitis even up to 37% (4-11). A 
large number of survivors suffer from long-term neurological sequelae (4). Various 
prognostic factors associated with adverse clinical outcome were reported so far (6-9,12,13). 
The most common factors independently associated with unfavorable outcome were 
APACHE II score >13, hypotension, seizures, obtunded mental state on admission, age over 
60 years and pneumococcal etiology (8,9,13,14). It is reasonable to believe that treatment 
outcome could be improved by timely and appropriate antibiotic therapy. Various recent 
studies have tried to assess the role of antibiotic timing in disease outcome, but final evidence 
is still lacking (5,12). 
The aim of this study was to evaluate antibiotic timing in the course of bacterial meningitis 
and outcome of the disease.  
 
 
 
 
 
 
 
 
  
5
PATIENTS AND METHODS 
Data collection 
The study was performed at the Zagreb Hospital for Infectious Diseases, a tertiary care, 
university-affiliated teaching hospital with 320 beds. The patients were identified through the 
hospital’s computerized data system based on diagnosis at discharge. The original written 
patient medical records were used to collect the data. The following parameters were 
recorded: age, gender, co-existing diseases, presenting symptoms, physical and neurological 
signs, cerebrospinal fluid (CSF) characteristics, laboratory results on admission, 
microbiological findings in CSF and blood, clinical outcome, treatment and timing of 
adequate antibiotic related to the onset of disease, the onset of consciousness disturbance and 
the time of admission to hospital.  We constructed a computerized database that included all 
patients discharged from our hospital with a diagnosis of bacterial meningitis between 1 
January 1990 to 31 December 2004. Microsoft Access 2002 software was used to create the 
database.  
Patients’ selection 
A total of 353 first episodes of bacterial meningitis were treated in our hospital in the 
fifteen-year observational period. One hundred and seventy patients were excluded from the 
study because of age below 14 years (20 patients), presence of brain abscess or subdural 
empyema (17 patients), meningitis limited to the spinal area (4 patients), nosocomial and 
shunt meningitis (126 patients) and certain reasons not associated with bacterial meningitis (3 
patients who died of pulmonary embolism, myocardial infarction and renal failure, 
respectively).  
Antibiotic timing could not be determined in 67 patients who were also excluded from the 
analysis. In order to test possible selection bias, a bivariate analysis was performed and 
showed no differences in relevant demographic and clinical variables (outcome, age, etiology, 
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mechanical ventilation, duration of hospitalization and administration of corticosteroids) 
between these and the remaining patients. Overall, 286 patients remained in the study to test 
the association of antibiotic timing and disease outcome. Further analysis was also performed 
in a subgroup of culture positive meningitis in patients with altered mental status. 
Definitions 
Bacterial meningitis was diagnosed on the basis of a compatible clinical picture and a positive 
CSF culture; or a negative CSF culture with a positive CSF bacterial antigen test; or a 
positive blood culture; or a positive Gram stain of a CSF sample. A culture negative bacterial 
meningitis was diagnosed on the basis of a compatible clinical picture, neutrophilic 
pleocytosis (≥ 10 white cells/ml of CSF with more than 50% neutrophils), CSF-blood glucose 
ratio <0,4 and CSF protein concentration >0,450 g/l. Bacterial meningitis was considered 
community-acquired if the patients had never been previously hospitalized or the onset of the 
disease occurred 2 weeks after discharging from hospital or 4 weeks after a surgical treatment 
(8).  
Mental status was assessed using the Glasgow Coma Scale score (GCS) and the recorded 
scores were the worst during 24 hours after admission to the hospital because of greater 
validity, to our opinion, in estimating disease severity (15). Altered mental status was defined 
as GCS < 15. The onset times of first symptoms and consciousness disturbance were obtained 
from housemates during medical history taking. The onset of disease was defined with first, 
nonspecific symptoms (fever, headache, malaise, vomiting). Focal neurological deficit was 
defined as aphasia, cranial-nerve palsy, monoparesis or hemiparesis on admission. 
Hypotension was defined as mean arterial pressure (MAP) < 70 mmHg. 
Appropriate therapy was defined as a regimen to which one or more of the bacteria 
isolated at baseline were sensitive, administered in adequate doses and which penetrates well 
into the CSF. The timing of appropriate antibacterial treatment was assessed regarding the 
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onset of the disease, the onset of consciousness disturbance and the time of admission to 
hospital.  
The majority of patients received empirical therapy with ceftriaxone alone (80/286; 
27,9%) or in combination with ampicillin, followed with penicillin G-sodium (55/286; 
19,2%) and cefotaxime (27/286; 9,4%). Diverse combinations of antibiotics were used in 99 
patients (34,6%). 
Underlying medical condition(s) were classified according to the modified criteria by Knaus 
(16): A) no known underlying diseases, B) presence of mild chronic diseases with slight 
functional limitation, C) severe chronic diseases with severe limitation, requiring constant 
medical surveillance, D) bed-ridden patients in terminal stages of underlying diseases (e.g. 
severe dementia, malignant diseases with metastases, decompensated liver cirrhosis etc.). 
Renal lesion on admission was defined as increased creatinine concentration above the upper 
limit of the normal range. Liver lesion was defined as increased bilirubin and/or 
aminotransferases levels above the upper limit of the normal range.  
The patients were stratified into two groups according to disease outcome: favorable and 
unfavorable. The patients’ clinical outcome was assessed by using the Glasgow Outcome 
Scale score (GOS) at the time of discharge from the hospital (17). Unfavorable clinical 
outcomes included death (GOS 1), vegetative state (GOS 2), severe neurological deficit (GOS 
3) and moderate disability (GOS 4). GOS 5 (mild or no disability) was considered a favorable 
outcome. 
Statistical analysis 
Univariate statistics included calculation of mean value, standard deviation, median and 
interquartiles for continuous variables. Values for categorical variables were presented as 
frequencies. The primary outcome variable was the Glasgow Outcome Score. Bivariate 
statistics assessed the differences between favorable and unfavorable groups. All relevant 
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demographic, clinical and laboratory variables of both groups were compared. To contrast the 
quantitative variables, nonparametric Mann-Whitney's test was used. For categorical data the 
chi-square test and the Fisher’s exact test when appropriate, were used. Logistic regression 
analysis was performed to ascertain the independent predictive potential of antibiotic timing, 
after adjustment for potential confounding variables. Missing data other than timing were 
recollected from patients’ charts or archived laboratory reports. Criteria for inclusion of 
variables in the logistics regression models were based on findings from previous studies, 
current clinical practice and evidence of an association (p<0,1) in the bivariate analysis. The 
appropriateness of the fitted model and its predictive utility were confirmed. Summary 
measures of goodness of fit were evaluated using the Hosmer-Lemeshow test. Interactions 
were assessed running correlation matrix and/or logit. Two- tailed p values less than 0,05 
were considered statistically significant. Data were analyzed using the ‘SPSS’ (SPSS Inc.), 
and ‘SAS’ software. 
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RESULTS 
 
Demographic, clinical and laboratory characteristics of patients are presented in table 1. The 
overall mortality was 22,7% (65/286).  
The triad of fever, neck stiffness and change in mental status was recorded in 73,7% of 
patients (211/286). Only 123 (58,2%) of these patients received appropriate antibiotic 
treatment within 24 hours from the onset of consciousness disturbance while in 88 patients 
(41,7%) adequate antibiotic was applied after more than 24 hours. Favorable outcome in the 
former group was 60,1% (74/123) versus 17% (15/88) in the latter. 35,5% of these patients 
(75/211) had sought medical attention prior to admission to hospital and in 49,3% (37/75) 
cases inappropriate antibiotic was prescribed.  
The outcome groups differed in disease severity assessed by the presence of specific organ 
system dysfunction or failure. The incidence of hypotension and respiratory failure which 
required mechanical ventilation was significantly higher in the unfavorable as opposed to the 
favorable group (24,8% vs. 3,1% and 76,8% vs. 13%). Some laboratory indicators of a more 
severe disease such as renal and liver lesion, and lower number of thrombocytes were also 
more often present in the unfavorable group (table 1). However, not in one patient could liver 
lesion be considered as liver failure. Only a mild increase of transaminases was observed.  
The etiology of meningitis was confirmed in 220 (76,9%) patients. The most common 
pathogen was Streptococcus pneumoniae, followed by Neisseria meningitidis, Listeria 
monocytogenes and Haemophilus influenzae. All other Gram negative bacteria were recorded 
in 29 patients (10,1%). Pneumococcal disease was more common in the unfavorable group 
(47,2% vs. 33,5%) (table 1). Important difference was also noted for 'other Gram negative' 
bacteria (known as high case-fatality rate associated etiology) which were more common in 
the unfavorable group.  
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 The most prominent difference was noted in antibiotic timing related to the onset of 
disease and the onset of consciousness disturbance which were more delayed in the 
unfavorable group (table 1). Appropriate treatment was started immediately (in the first hour 
from admission) in 263 patients (91,9%). In 23 patients the choice of antibiotic was 
inappropriate. We recorded a mean of 1,21 days from hospitalization to the start of 
appropriate therapy (table 1). 
To identify possible risk factors (independent variables) of poor outcome besides antibiotic 
timing, a bivariate analysis was performed between the patients with poor outcome and those 
with favorable outcome (table 1). A bivariate analysis identified a number of factors which 
might increase the risks of unfavorable outcome in patients with bacterial meningitis. Among 
baseline parameters, advanced age and premorbid states were significantly associated with 
poor outcome. Other factors were those associated with clinical presentation of meningitis 
(disturbed consciousness, seizures, neurological deficits), and those associated with the 
severity of sepsis such as organ dysfunction/failures and shock. Pneumococcal disease was 
identified as a risk factor as well as ‘other Gram negative’ etiology (table 1). 
These variables were included in the logistic regression analysis. Platelets count and 
positive CSF culture were not included in the analysis although p-value was <0.1 because we 
considered these differences clinically insignificant. We also excluded the use of steroids 
because of inconsistencies throughout the observation period particularly regarding their 
timing in relation to the start of antimicrobial treatment. Therefore, besides antibiotic timing 
according to the onset of disease, the following variables were included in the logistic 
regression analysis: age, presence of co-existing chronic diseases, Glasgow Coma Score, 
seizures, presence of focal neurological deficit, hypotension, CSF/blood glucose ratio, 
presence of renal lesion, liver dysfunction, and pneumococcal etiology. 
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The results of the multivariate analysis and independent variables included in the model 
are presented in table 3. Multicollinearity was not found for any combination of variables.  
Likelihood ratio test showed that our model significantly better accounts for outcome than 
would be expected by chance (- Log likelihood difference 84,836, degrees of freedom 11, 
p<0,001). Model was well-fitting (chi-square 222.264, p=0.98). The model explained 82.9 % 
of outcomes. Delay in the appropriate treatment was significantly associated with unfavorable 
outcome (OR=2,8; 95%CI 1,13-7; p=0,026) (table 3). Advanced age, focal neurological 
deficit and disturbed consciousness expressed as lower Glasgow Coma Score were other 
variables associated with poor outcome. Other factors such as seizures, the presence of 
chronic diseases, glucose in CSF/blood ratio, renal lesion, hypotension, liver lesion and 
pneumococcal etiology were not independently associated with poor outcome. 
The analysis of factors associated with poor outcome was repeated in a subgroup of 
patients with confirmed etiology and impaired consciousness. A bivariate analysis of 
demographic and clinical characteristics in this subgroup showed similar results as in the 
whole group except that the presence of focal neurological deficit and etiology were not 
significantly associated with unfavorable outcome (table 2). The following variables were 
included in the logistic regression analysis of this subgroup: age, presence of co-existing 
chronic diseases, Glasgow Coma Score, seizures, hypotension and CSF/blood glucose ratio 
and the start of appropriate therapy related to the onset of consciousness disturbance. The 
results of the multivariate analysis of this subgroup are shown in table 4. Likelihood ratio test 
showed that our model significantly better accounts for outcome than would be expected by 
chance (- Log likelihood difference 48.45, degrees of freedom 6, p<0.001). Model was well-
fitting (chi-square 141.9 , p=0.903). The model explained 81.2 of outcomes. A delay in 
appropriate treatment related to the onset of consciousness disturbance was the most 
important variable associated with unfavorable outcome (OR=11,19; 95%CI 4,37-32,57; 
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p<0,001 ) (table 4). Advanced age, seizures and disturbed consciousness expressed as lower 
Glasgow Coma Score were other important variables associated with poor outcome. The 
presence of chronic diseases, hypotension and low glucose CSF/blood ratio were not 
independently associated with poor outcome. 
 
DISCUSSION 
Our retrospective, single-center study evaluated characteristics of bacterial meningitis in 
the fifteen-year period. We found that advanced age, disturbed consciousness, seizures and 
neurological deficits as well as the presence of multiorgan dysfunction and shock are 
independently associated with unfavorable outcome. We also found that antimicrobial 
treatment is also associated with clinical outcome in adult patients with community-acquired 
bacterial meningitis particularly when its start is related to the onset of consciousness 
disturbance. Other factors reported in previous studies (6-9,13,18) like comorbidity, 
hypotension and focal neurological deficits were not independently associated with poor 
outcome in our cohort of patients. The etiology of meningitis did not show a significant 
impact on patients’ outcome. 
A relatively high proportion of mechanically ventilated patients (40,9%) in our study is a 
consequence of disease severity. In these patients the median value of GCS was 7, and the 
mortality rate 55,5% (65/117).  
The importance of door-to-antibiotic time was assessed in recent studies but these studies 
did not evaluate the duration of illness and meningitis before admission to hospital (19,20). 
We tried to overcome this by relating the time of appropriate therapy for meningitis to the 
onset of the first symptoms which might be associated with meningitis (e.g. fever, headache, 
vomiting, malaise etc.) and to the time of the onset of consciousness disturbance. We 
recognize that the definitions we used for the timing of appropriate antibiotic therapy are not 
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completely precise and that using hours, instead of days, would have been much more 
informative. Unfortunately, this is a retrospective study and precise data could not be 
obtained from the records of many patients. Despite this limitation, our study has showed that 
timing, even if represented as a dichotomous variable as we did, has an impact on disease 
outcome.  
We recognize several other limitations of our study. The first is its retrospective nature. 
However, good clinical practice in our institution enabled us to collect all relevant data and 
include a representative number of patients satisfying acceptable power of the study. The 
second is that the observational period was long, and in this period a number of changes 
occurred, particularly in treating patients in critical care setting. Third, we were not able to 
assess the influence of dexamethasone treatment because of inconsistencies in its use until 
few years ago, when we established the necessity of its use and timing in our hospital`s 
treatment guidelines for adult patients with bacterial meningitis.  
Despite limitations of our study, we believe that early, appropriate antibiotic treatment 
increases chances of favorable outcome in patients with bacterial meningitis. Only twenty 
percent of our patients received appropriate treatment during the first twenty-four hours of the 
disease. It is hard to influence the time between disease onset and the first medical contact. 
However, urgent diagnostic and treatment procedure in every suspicious case of bacterial 
meningitis during the first medical contact is of utter importance. The use of antibiotics 
without established diagnosis leads to a delay in adequate treatment of severe infections. We 
did not identify specific factors associated with tardy treatment. Other studies found that 
unnecessary diagnostic procedures could also result in late diagnosis and treatment of patients 
with bacterial meningitis (5,21,22). 
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In conclusion, our study emphasizes the importance of early and adequate antibiotic treatment 
in bacterial meningitis. Although time intervals that we used might need more strict 
definitions, our results showed their association with disease outcome. 
The results of our study should increase alertness of physicians to diagnose and promptly 
treat bacterial meningitis immediately after the first contact with the patient.  
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TABLE  1    Baseline demographic data and characteristics of bacterial meningitis in 286 patients  
 
 
all patients 
 
n=286 
favorable group 
(GOS = 5)  
n=161 
unfavorable group 
(GOS ≤ 4)  
n=125 
 
p  
age (years)       
                       mean±SD 
                       median (interquartiles)                     
 
47,4±18,5 
49 (33-62) 
 
40,5±17,3 
39 (25-52) 
 
56,3±16,1 
58 (45-70) 
 
<0,001 
sex                                 male 
                                      female 
 
179 (62,58%) 
107 (37,41%) 
103 (63,9%) 
58 (36,1%) 
76 (60,8%) 
49 (39,2%) 
0,66 
co-existing diseases 117 (40,9%) 43 (26,7%) 74 (59,2%) <0,001 
prior antibiotic treatment 107 (37,4%) 61 (37,8%) 46 (36,8%) 0,94 
GCS 
                        mean±SD 
                        median (interquartiles)                     
 
12,85±3,68 
11(8-15) 
 
12,7±2,9 
14 (11-15) 
 
8,3±3,0 
8 (7-10) 
 
<0,001 
     
seizures 48 (16,7%) 12 (7,4%) 36 (28,8%) <0,001 
focal neurological deficit 28 (9,7%) 6 (3,7%) 22 (17,6%) <0,001 
triad of fever, neck stiffness  and change 
in  mental status  
211 (73,7%) 90 (55,9%) 121 (96,8%) < 0,001 
adjuvant dexamethasone therapy 106 (37%) 52 (32,2%) 54 (43,2%) 0,07 
hypotension 36 (12,5%) 5 (3,1%) 31 (24,8%) <0,001 
respiratory failure requiring 
mechanical ventilation 
 
117 (40,9%) 
 
21 (13%) 
 
96 (76,8%) 
 
<0,001 
AT* - onset of disease (days) 
                       mean±SD 
                       median (interquartiles) 
 
3,14±2,17 
3 (2-4) 
 
2,9±2,1 
2 (1-4) 
 
3,4±2,1 
3 (2-4) 
 
0,018 
AT*- onset of consciousness disturbance   
                         (days) 
                       mean±SD 
                       median (interquartiles) 
 
 
1,53±1,22 
1 (1-2) 
 
 
1,13±0,44 
1 (1-1) 
 
 
2,06±1,63 
2 (1-2) 
 
 
<0,001 
AT* – time of admission to hospital  
                       (days) 
                       mean±SD 
                       median (interquartiles) 
 
 
1,21±0,9 
1 (1-1) 
 
 
1,11±0,5 
1 (1-1) 
 
 
1,33±1,23 
1 (1-1) 
 
 
0,411 
Etiology:     
     S. pneumoniae 113 (39,5%) 54 (33,5%) 59 (47,2%) 0,02 
     Neisseria meningitidis 24 (8,3%) 19 (11,8%) 5 (4%) 0,031 
     Listeria monocytogenes 19 (6,6%) 12 (7,4%) 7 (5,6%) 0,70 
     H.influenzae 16 (5,5%) 11 (6,8%) 5 (4%) 0,43 
     other Gram-negative bacteria 29 (10,1%) 9 (5,5%) 20 (16%) 0,007 
     
positive blood culture 96 (33,5%) 50 (31%) 47 (37,6%) 0,30 
positive CSF culture 197 (68,8%) 104 (64,5%) 93 (74,4%) 0,09 
positive Gram stain of a CSF sample 156 (54,5%) 81 (50,3%) 75 (60%) 0,13 
     
pleocytosis (cells/3 mm3)  
           mean±SD 
           median (interquartiles) 
 
 
22007±32166 
12000 (253-26680) 
 
18394±19860 
13056 (3840-
24320) 
 
26660±42782 
11264 (4800-30720) 
 
0,65 
CSF/blood glucose ratio 
           mean±SD 
           median (interquartiles) 
 
0,235±0,221 
0,189 (0,022-0,385) 
 
0,30±0,23 
0,28 (0,089-0,45) 
 
0,16±0,19 
0,07 (0,01-0,27) 
 
<0,001 
     
renal dysfunction                43 (15%) 15 (9,3%) 28 (22,4%) 0,003 
liver dysfunction  103 (36%) 38 (23,6%) 65 (52%) <0,001 
platelets count (× 109/L) 
           mean±SD 
           median (interquartiles) 
 
 
194,2±96,8 
187,5 (136-235) 
 
199,28±81,74 
192 (153-235) 
 
187,84±113,33 
174 (109-234) 
 
0,07 
 
    * antibiotic timing according to the – 
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TABLE  2     Bivariate analysis of demographic data and characteristics in 176 patients with   
                                  altered mental status  and culture positive bacterial meningitis                                                    
   
 
 
all patients 
n=176 
favorable group 
(GOS = 5)  
n=73 
unfavorable group 
(GOS ≤ 4)  
n=103 
 
p  
age (years)       
                       mean±SD 
                       median (interquartiles)    
 
51,8±17,9 
54 (39,5-65,5) 
 
43,7±17,5 
47 (29-56) 
 
57,5±15,8 
59 (47-70) 
 
<0,001 
co-existing diseases 90 (51,1%) 25 (34,2%) 65 (63,1%) <0,001 
prior antibiotic treatment 57 (32,3%) 19 (26%) 38 (36,8%) 0,175 
GCS 
                       mean±SD 
                       median (interquartiles)                     
 
9,06±3,0 
9 (7-11) 
 
10,6±2,9 
11 (9-13) 
 
7,9±2,5 
8 (6-10) 
 
<0,001 
     
seizures 39 (22,1%) 7 (9,5%) 32 (31%) 0,0013 
focal neurological deficit 22 (12,5%) 5 (6,8%) 17 (16,5%) 0,093 
adjuvant dexamethasone therapy 76 (43,1%) 31 (42,4%) 45 (43,6%) 0,99 
hypotension 32 (18,1%) 4 (5,4%) 28 (27,1%) <0,001 
respiratory failure requiring 
mechanical ventilation 
 
 
105 (59,6%) 
 
19 (26%) 
 
86 (83,4) 
 
<0,001 
AT* - onset of disease (days) 
                       mean±SD 
                       median (interquartiles) 
 
3,0±2,0 
3 (2-4) 
 
2,5±1,67 
2 (1-3) 
 
3,41±2,21 
3 (2-4) 
 
0,002 
AT*- onset of consciousness  
         disturbance (days) 
                       mean±SD 
                       median (interquartiles) 
 
 
1,73±1,36 
1 (1-2) 
 
 
1,21±0,55 
1 (1-1) 
 
 
2,09±1,63 
2 (1-2) 
 
 
<0,001 
AT* – time of admission  
           to hospital (days) 
                       mean±SD 
                       median (interquartiles) 
 
 
1,27±1,0 
1 (1-1) 
 
 
1,09±0,41 
1 (1-1) 
 
 
1,4±1,34 
1 (1-1) 
 
 
0,351 
Etiology:     
     S. pneumoniae 100 (56,8%) 44 (60,2%) 56 (54,3%) 0,532 
     Neisseria meningitidis 13 (7,3%) 8 (10,9%) 5 (4,8%) 0,217 
     Listeria monocytogenes 14 (7,9%) 7 (9,5%) 7 (6,7%) 0,695 
     H.influenzae 12 (6,8%) 7 (9,5%) 5 (4,8%) 0,355 
     other Gram-negative bacteria 18 (10,2%) 5 (6,8%) 13 (12,6%) 0,320 
     
positive blood culture 82 (46,5%) 37 (50,6%) 45 (43,6%) 0,445 
positive CSF culture 162 (92%) 71 (97,2%) 91 (88,3%) 0,061 
positive Gram stain of a CSF sample 129 (73,2%) 56 (76,7%) 73 (70,8%) 0,49 
     
pleocytosis (cells/3 mm3)  
           mean±SD 
           median (interquartiles) 
 
 
27044±37986 
15360 (5120-33280) 
 
24783±24629 
16640 (8192-33280) 
 
28647±45179 
12800 (4800-33280) 
 
0,383 
CSF/blood glucose ratio 
           mean±SD 
           median (interquartiles) 
 
0,162±0,197 
0,07 (0,009-0,274) 
 
0,205±0,211 
0,159 (0,018-0,352) 
 
0,132±0,181 
0,048 (0,008-0,213) 
 
0,018 
     
renal dysfunction                33 (18,7%) 9 (12,3%) 24 (23,3%) 0,1 
liver dysfunction                79 (44,8%) 22 (30,1%) 57 (55,3%) 0,0016 
platelets count (× 109/L) 
           mean±SD 
           median (interquartiles) 
 
 
183±101 
171 (123-226) 
 
181±68 
184 (144-213) 
 
185±120 
162 (97-234) 
 
0,516 
   
* antibiotic timing according to the – 
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TABLE  3   Logistic regression analysis  of independent risk factors associated with unfavorable                          
outcome in  286 patients with bacterial meningitis 
 
 
 
 
 
 
 
 
 
 
* start of appropriate antibiotic treatment  > 24 hours after the first symptoms associated with meningitis 
 
 
Variable OR 95% confidence 
interval 
p 
 antibiotic timing * 2,8 1.13  – 7 0,026 
age (increase per year) 1,04 1,01  - 1,06 <0,001 
GCS (decrease per one 
point) 
1,47 1,29 – 1,7 <0,001 
focal neurological 
deficits 
 
3.80 
 
1.15 – 12,58 
 
0,029 
presence of chronic 
diseases 
 
2.32 
 
0.96– 3.98 
 
0,063 
seizures 
(yes) 
 
2.33 
 
0.87 – 6.24 
 
0,09 
CSF/blood glucose ratio  
≤ 0.2 
 
1.79 
 
0,85 – 3.75 
 
0.124 
renal  dysfunction               1.88 0.73 – 4.76 0.188 
hypotension 3.21 0.68 – 15.08 0.140 
liver dysfunction 1.77 0.87 – 3.60 0.115 
pneumococcal disease 1.38 0.61 – 3.15 0.437 
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TABLE 4       Logistic regression analysis of independent risk factors associated with unfavorable              
outcome in 176 patients with altered mental status and culture positive bacterial meningitis  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* start of appropriate antibiotics >24 hours after the impairment of consciousness  
 
 
Variable OR 95% confidence 
interval 
p 
antibiotic timing * 11.19  4.37 – 32.57  <0.001 
age ( increase per one 
year) 
1.05 1.03 – 1.09  <0.001 
GCS (decrease per one 
point) 
1.45 1.21 – 1.74  <0.001 
seizures 
(yes) 
3.65 1.08 – 12.27 0.037 
presence of chronic 
diseases 
1.68 0.68 – 4.15 0.258 
hypotension 1.57 0.28 – 8.72 0.607 
CSF/blood glucose 
ratio ≤ 0.2 
1.62 0.66 – 3.99 0.293 
